![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
J Raber, GF Koob and FE Bloom
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California.
Interleukin-2 (IL-2)-like immunoreactivity and IL-2 receptor immunoreactivity have been reported in different brain regions, under normal and pathophysiological conditions. IL-2 stimulates hypothalamic corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) release and that of pituitary adrenocorticotropin. The amygdala, known to contain high levels of CRF, is involved in stress-related reactions, including regulation of the hypothalamo-pituitary-adrenal axis. IL-2 will release AVP from both the hypothalamus and the amygdala, which further supports a role for cytokine effects in the amygdala in neuroimmune interactions. In the present study, we compared the effects of IL-2, acetylcholine and norepinephrine on the in vitro release of CRF from the amygdala or hypothalamus. In addition, we used these release systems to evaluate the possible involvement of nitric oxide (NO)-mediated signaling in CRF release. IL-2 stimulates CRF release in both regions, in a calcium- and dose-dependent manner. Nitroprusside, an NO generator, also induces CRF release. This IL-2-induced CRF release is antagonized by Ng-methyl-L-arginine and hemoglobin, known NO antagonists. Finally, norepinephrine and acetylcholine induce CRF release. The norepinephrine-induced CRF release is antagonized by phentolamine and propanolol and the acetylcholine-induced release by atropine and mecamylamine, which suggests the involvement of both alpha and beta adrenergic receptors and both muscarinic and nicotinic receptors. The acetylcholine-induced CRF release is antagonized by Ng- methyl-L-arginine, but the norepinephrine-induced response is not. These data support the suggestion that the amygdala may participate in communications between the neuroendocrine and immune systems.
This article has been cited by other articles:
|
|
 |
|
  L. K. Heisler, N. Pronchuk, K. Nonogaki, L. Zhou, J. Raber, L. Tung, G. S. H. Yeo, S. O'Rahilly, W. F. Colmers, J. K. Elmquist, et al. Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation J. Neurosci., June 27, 2007; 27(26): 6956 - 6964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Brady and R. Sinha Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress Focus, January 1, 2007; 5(2): 229 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Brady and R. Sinha Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress Am J Psychiatry, August 1, 2005; 162(8): 1483 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. L. M. Pepels, S. E. W. Bonga, and P. H. M. Balm Bacterial lipopolysaccharide (LPS) modulates corticotropin-releasing hormone (CRH) content and release in the brain of juvenile and adult tilapia (Oreochromis mossambicus; Teleostei) J. Exp. Biol., December 1, 2004; 207(25): 4479 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Jacobsen, S. M. Southwick, and T. R. Kosten Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature Am J Psychiatry, August 1, 2001; 158(8): 1184 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Kim and C. L. Rivier Nitric Oxide and Carbon Monoxide Have a Stimulatory Role in the Hypothalamic-Pituitary-Adrenal Response to Physico-Emotional Stressors in Rats Endocrinology, June 1, 2000; 141(6): 2244 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Kusnecov, R. Liang, and G. Shurin T-Lymphocyte Activation Increases Hypothalamic and Amygdaloid Expression of CRH mRNA and Emotional Reactivity to Novelty J. Neurosci., June 1, 1999; 19(11): 4533 - 4543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jasmin, G. Janni, H. J. Manz, and S. D. Rabkin Activation of CNS Circuits Producing a Neurogenic Cystitis: Evidence for Centrally Induced Peripheral Inflammation J. Neurosci., December 1, 1998; 18(23): 10016 - 10029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.V. Milanés, M.L. Laorden, M. Chapleur-Château, and A. Burlet Alterations in Corticotropin-Releasing Factor and Vasopressin Content in Rat Brain during Morphine Withdrawal: Correlation with Hypothalamic Noradrenergic Activity and Pituitary-Adrenal Response J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 700 - 706. [Abstract] [Full Text]
|
|
|
|
|
|
J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Kasckow, A. Regmi, P. S. Gill, D. G. Parkes, and T. D. Geracioti Regulation of Corticotropin-Releasing Factor (CRF) Messenger Ribonucleic Acid and CRF Peptide in the Amygdala: Studies in Primary Amygdalar Cultures Endocrinology, November 1, 1997; 138(11): 4774 - 4782. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
